Literature DB >> 30571284

Type 2 diabetes mellitus in the Goto-Kakizaki rat impairs microvascular function and contributes to premature skeletal muscle fatigue.

Jefferson C Frisbee1, Matthew T Lewis2, Jonathan D Kasper2, Paul D Chantler3, Robert W Wiseman2,4.   

Abstract

Despite extensive investigation into the impact of metabolic disease on vascular function and, by extension, tissue perfusion and organ function, interpreting results for specific risk factors can be complicated by the additional risks present in most models. To specifically determine the impact of type 2 diabetes without obesity on skeletal muscle microvascular structure/function and on active hyperemia with elevated metabolic demand, we used 17-wk-old Goto-Kakizaki (GK) rats to study microvascular function at multiple levels of resolution. Gracilis muscle arterioles demonstrated blunted dilation to acetylcholine (both ex vivo proximal and in situ distal arterioles) and elevated shear (distal arterioles only). All other alterations to reactivity appeared to reflect compromised endothelial function associated with increased thromboxane (Tx)A2 production and oxidant stress/inflammation rather than alterations to vascular smooth muscle function. Structural changes to the microcirculation of GK rats were confined to reduced microvessel density of ~12%, with no evidence for altered vascular wall mechanics. Active hyperemia with either field stimulation of in situ cremaster muscle or electrical stimulation via the sciatic nerve for in situ gastrocnemius muscle was blunted in GK rats, primarily because of blunted functional dilation of skeletal muscle arterioles. The blunted active hyperemia was associated with impaired oxygen uptake (V̇o2) across the muscle and accelerated muscle fatigue. Acute interventions to reduce oxidant stress (TEMPOL) and TxA2 action (SQ-29548) or production (dazmegrel) improved muscle perfusion, V̇o2, and muscle performance. These results suggest that type 2 diabetes mellitus in GK rats impairs skeletal muscle arteriolar function apparently early in the progression of the disease and potentially via an increased reactive oxygen species/inflammation-induced TxA2 production/action on network function as a major contributing mechanism. NEW & NOTEWORTHY The impact of type 2 diabetes mellitus on vascular structure/function remains an area lacking clarity. Using diabetic Goto-Kakizaki rats before the development of other risk factors, we determined alterations to vascular structure/function and skeletal muscle active hyperemia. Type 2 diabetes mellitus reduced arteriolar endothelium-dependent dilation associated with increased thromboxane A2 generation. Although modest microvascular rarefaction was evident, there were no other alterations to vascular structure/function. Skeletal muscle active hyperemia was blunted, although it improved after antioxidant or anti-thromboxane A2 treatment.

Entities:  

Keywords:  animal models of diabetes; endothelial dysfunction; metabolic disease; regulation of blood flow; vascular dysfunction

Mesh:

Substances:

Year:  2018        PMID: 30571284      PMCID: PMC6459383          DOI: 10.1152/japplphysiol.00751.2018

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  50 in total

1.  Flow velocity-dependent regulation of microvascular resistance in vivo.

Authors:  A Koller; G Kaley
Journal:  Microcirc Endothelium Lymphatics       Date:  1989-12

2.  Distinct temporal phases of microvascular rarefaction in skeletal muscle of obese Zucker rats.

Authors:  Jefferson C Frisbee; Adam G Goodwill; Stephanie J Frisbee; Joshua T Butcher; Robert W Brock; I Mark Olfert; Evan R DeVallance; Paul D Chantler
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-10-10       Impact factor: 4.733

3.  Myogenic vasoregulation overrides local metabolic control in resting rat skeletal muscle.

Authors:  G A Meininger; C A Mack; K L Fehr; H G Bohlen
Journal:  Circ Res       Date:  1987-06       Impact factor: 17.367

4.  Divergence between arterial perfusion and fatigue resistance in skeletal muscle in the metabolic syndrome.

Authors:  Jefferson C Frisbee; Adam G Goodwill; Joshua T Butcher; I Mark Olfert
Journal:  Exp Physiol       Date:  2010-12-01       Impact factor: 2.969

5.  Metformin delays the manifestation of diabetes and vascular dysfunction in Goto-Kakizaki rats by reduction of mitochondrial oxidative stress.

Authors:  Peter Rösen; Nicolas F Wiernsperger
Journal:  Diabetes Metab Res Rev       Date:  2006 Jul-Aug       Impact factor: 4.876

6.  Effects of Type II diabetes on capillary hemodynamics in skeletal muscle.

Authors:  Danielle J Padilla; Paul McDonough; Brad J Behnke; Yutaka Kano; K Sue Hageman; Timothy I Musch; David C Poole
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-07-14       Impact factor: 4.733

Review 7.  Experimental rat models to study the metabolic syndrome.

Authors:  Amaya Aleixandre de Artiñano; Marta Miguel Castro
Journal:  Br J Nutr       Date:  2009-07-27       Impact factor: 3.718

8.  Increased peripheral vascular disease risk progressively constrains perfusion adaptability in the skeletal muscle microcirculation.

Authors:  Jefferson C Frisbee; Joshua T Butcher; Stephanie J Frisbee; I Mark Olfert; Paul D Chantler; Lawrence E Tabone; Alexandre C d'Audiffret; Carl D Shrader; Adam G Goodwill; Phoebe A Stapleton; Steven D Brooks; Robert W Brock; Julian H Lombard
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-12-23       Impact factor: 4.733

9.  Characterization of the ZDSD Rat: A Translational Model for the Study of Metabolic Syndrome and Type 2 Diabetes.

Authors:  Richard G Peterson; Charles V Jackson; Karen Zimmerman; Willem de Winter; Norman Huebert; Michael K Hansen
Journal:  J Diabetes Res       Date:  2015-04-16       Impact factor: 4.011

10.  Genomic and metabolic disposition of non-obese type 2 diabetic rats to increased myocardial fatty acid metabolism.

Authors:  Sriram Devanathan; Samuel T Nemanich; Attila Kovacs; Nicole Fettig; Robert J Gropler; Kooresh I Shoghi
Journal:  PLoS One       Date:  2013-10-21       Impact factor: 3.240

View more
  7 in total

1.  Skeletal muscle energetics are compromised only during high-intensity contractions in the Goto-Kakizaki rat model of type 2 diabetes.

Authors:  Matthew T Lewis; Jonathan D Kasper; Jason N Bazil; Jefferson C Frisbee; Robert W Wiseman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-06-12       Impact factor: 3.619

2.  Endothelium-dependent impairments to cerebral vascular reactivity with type 2 diabetes mellitus in the Goto-Kakizaki rat.

Authors:  Brayden D Halvorson; Shawn N Whitehead; John J McGuire; Robert W Wiseman; Jefferson C Frisbee
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-05-15       Impact factor: 3.619

Review 3.  Exaggerated exercise pressor reflex in type 2 diabetes: Potential role of oxidative stress.

Authors:  Ann-Katrin Grotle; Audrey J Stone
Journal:  Auton Neurosci       Date:  2019-10-21       Impact factor: 3.145

Review 4.  Effects of impaired microvascular flow regulation on metabolism-perfusion matching and organ function.

Authors:  Tuhin K Roy; Timothy W Secomb
Journal:  Microcirculation       Date:  2020-12-21       Impact factor: 2.679

5.  Improved Survival and Retinal Function of Aging ZDF Rats in Long-Term, Uncontrolled Diabetes by BGP-15 Treatment.

Authors:  Zita Wachal; Anna Szilágyi; Barbara Takács; Adrienn Mónika Szabó; Dániel Priksz; Mariann Bombicz; Judit Szilvássy; Béla Juhász; Zoltán Szilvássy; Balázs Varga
Journal:  Front Pharmacol       Date:  2021-04-16       Impact factor: 5.988

6.  Single-leg exercise training augments in vivo skeletal muscle oxidative flux and vascular content and function in adults with type 2 diabetes.

Authors:  Rebecca L Scalzo; Irene E Schauer; Deirdre Rafferty; Leslie A Knaub; Nina Kvaratskhelia; Taro Kaelix Johnson; Gregory B Pott; Layla A Abushamat; Mary O Whipple; Amy G Huebschmann; Melanie Cree-Green; Jane E B Reusch; Judith G Regensteiner
Journal:  J Physiol       Date:  2021-03-05       Impact factor: 5.182

Review 7.  Quantification of Mitochondrial Oxidative Phosphorylation in Metabolic Disease: Application to Type 2 Diabetes.

Authors:  Matthew T Lewis; Jonathan D Kasper; Jason N Bazil; Jefferson C Frisbee; Robert W Wiseman
Journal:  Int J Mol Sci       Date:  2019-10-24       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.